Prosecution Insights
Last updated: November 04, 2026
Application No. 19/175,075

GAIT-BASED ASSESSMENT OF NEURODEGENERATION

Non-Final OA §103§112§DOUBLEPATENT
Filed
Apr 10, 2025
Priority
Sep 04, 2019 — provisional 62/895,973 +2 more
Examiner
SCHWARTZ, RAPHAEL M
Art Unit
2671
Tech Center
2600 — Communications
Assignee
Gaitiq Inc.
OA Round
1 (Non-Final)
67%
Grant Probability
Favorable
1-2
OA Rounds
1y 4m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 67% — above average
67%
Career Allowance Rate
237 granted / 352 resolved
+5.3% vs TC avg
Strong +30% interview lift
Without
With
+29.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 11m
Avg Prosecution
27 currently pending
Career history
386
Total Applications
across all art units

Statute-Specific Performance

§101
7.3%
-32.7% vs TC avg
§103
52.0%
+12.0% vs TC avg
§102
5.8%
-34.2% vs TC avg
§112
19.5%
-20.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 352 resolved cases

Office Action

§103 §112 §DOUBLEPATENT
DETAILED ACTION Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claim 1 rejected on the ground of nonstatutory double patenting as being unpatentable over claims U.S. Patent Nos. 11,986,286 and 12,295,727. Although the claims at issue are not identical, they are not patentably distinct from each other: Regarding claim 1, 12,295,727 discloses a method for gait-based testing for a neurodegenerative condition in a patient, the method comprising: (claim 1) acquiring gait kinematic data for the patient, the gait kinematic data comprising one or more time-dependent signals each representing a kinematic parameter of a joint or body segment; (claim 1) processing the gait kinematic data with one or more computer processors to derive, from the one or more time-dependents signals, one or more respective gait metrics each indicative of a degree of variability, between curve segments for multiple strides within the respective time-dependent signal, in characteristic shapes of the curve segments; and (claim 1) operating a machine-learning model on input comprising the one or more gait metrics, using the one or more computer processors, to determine at least one predictive score associated with the neurodegenerative condition and the patient. (claim 1). The claims are similarly rejected by U.S. Patent No. 11,986,286. Claim Rejections - 35 USC § 112 The following is a quotation of the first paragraph of 35 U.S.C. 112(a): (a) IN GENERAL.—The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor or joint inventor of carrying out the invention. The following is a quotation of the first paragraph of pre-AIA 35 U.S.C. 112: The specification shall contain a written description of the invention, and of the manner and process of making and using it, in such full, clear, concise, and exact terms as to enable any person skilled in the art to which it pertains, or with which it is most nearly connected, to make and use the same, and shall set forth the best mode contemplated by the inventor of carrying out his invention. Claims 1 are rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the written description requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to reasonably convey to one skilled in the relevant art that the inventor or a joint inventor, or for applications subject to pre-AIA 35 U.S.C. 112, the inventor(s), at the time the application was filed, had possession of the claimed invention. Claim 1 requires, “processing the gait kinematic data with one or more computer processors to derive, from the one or more time-dependents signals, one or more respective gait metrics each indicative of a degree of variability, between curve segments for multiple strides within the respective time-dependent signal, in characteristic shapes of the curve segments” Examiner notes that Applicant has not required comparing successive strides to one another in any way. There is also no requirement for measuring inter-stride variance or variability. Rather, the requirement is simply for deriving metrics indicative of a degree of variability, between strides. Examiner finds that there is not any real disclosure of how this works in the Specification. The closest disclosure appears at ¶ 41-44 and 25. It is clear that the stride curves are obtained, but there is no real explanation anywhere on how this might work after the stride curves are obtained. These paragraphs along with Figs. 8 and 9 simply show that the stride curves are overlaid on top of one another. This is not a comparison between strides and there are no details on whether or how the strides are compared or how any analysis takes place that could produce ‘metrics indicative of a degree of variability.’ Without any explanation whatsoever, it would not be at all clear to ordinary skill in the art whether the inventor has been able to use this analysis in this way, or how this would be done. As such, Examiner finds that the disclosure is not adequate to reasonably convey to one skilled in the relevant art that the inventor had possession of the claimed invention. Nowhere does the disclosure explain how these “metrics indicative of a degree of variability” are determined. As such, the disclosure has not clearly conveyed that the Applicant has invented the required claimed subject matter. In re Barker, 559 F.2d 588, 592 n.4, 194 USPQ 470, 473 n.4 (CCPA 1977). To satisfy the written description requirement, a patent specification must describe the claimed invention in sufficient detail that one skilled in the art can reasonably conclude that the inventor had possession of the claimed invention. See, e.g., Moba, B.V. v. Diamond Automation, Inc., 325 F.3d 1306, 1319, 66 USPQ2d 1429, 1438 (Fed. Cir. 2003); MPEP 2163 (I)(A) states that “issues of adequate written description may arise even for original claims, for example, when an aspect of the claimed invention has not been described with sufficient particularity such that one skilled in the art would recognize that the inventor had possession of the claimed invention at the time of filing. The claimed invention as a whole may not be adequately described if the claims require an essential or critical feature which is not adequately described in the specification and which is not conventional or known in the art.” Claim 1 is rejected under 35 U.S.C. 112(a) or 35 U.S.C. 112 (pre-AIA ), first paragraph, as failing to comply with the enablement requirement. The claim(s) contains subject matter which was not described in the specification in such a way as to enable one skilled in the art to which it pertains, or with which it is most nearly connected, to make and/or use the invention. Examiner notes that the language above, “processing the gait kinematic data with one or more computer processors to derive, from the one or more time-dependents signals, one or more respective gait metrics each indicative of a degree of variability, between curve segments for multiple strides within the respective time-dependent signal, in characteristic shapes of the curve segments” was not described in the specification in such a way as to enable one skilled in the art to make and/or use the invention. The enablement requirement of 35 U.S.C. 112(a) or pre-AIA 35 U.S.C. 112, first paragraph, is separate and distinct from the written description requirement. Vas-Cath,Inc. v. Mahurkar, 935 F.2d 1555, 1563, 19 USPQ2d 1111, 1116-17 (Fed. Cir. 1991) Without repeating the entire analysis and claim construction above, Examiner notes that nowhere does the disclosure explain how “metrics indicative of a degree of variability” are determined. As such, the only conclusion is that language was not described in the specification in such a way as to enable one skilled in the art to make and/or use the invention. Nowhere does the disclosure explain or suggest how or what the process would be to perform the claimed function. Examiner notes that as per In re Wands, 858 F.2d at 737, 8 USPQ2d at 1404. the determination that “undue experimentation” would have been needed to make and use the claimed invention is not a single, simple factual determination. Rather, it is a conclusion reached by weighing the following noted factual considerations. (A) The breadth of the claims; (B) The nature of the invention; (C) The state of the prior art; (D) The level of one of ordinary skill; (E) The level of predictability in the art; (F) The amount of direction provided by the inventor; (G) The existence of working examples; (H) The quantity of experimentation needed to make or use the invention based on the content of the disclosure. As per MPEP 2164.04 it is not necessary to discuss each factor in the enablement rejection. Here in particular, the nature of the claimed invention was found to be something that the prior art does not disclose or suggest (factor B). The state of the art was carefully examined, as evidenced by citation of multiple references related to the claim requirements below (factor C), and level of one of ordinary skill and predictability of the art was noted as someone familiar with gait analysis (factors D and E). The quantity of experimentation (factor H) was assessed and noted that experimentation would be very high as the claim requirement describes something which the description contains no genuine explanation for. The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 1 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The claim language “processing the gait kinematic data with one or more computer processors to derive, from the one or more time-dependents signals, one or more respective gait metrics each indicative of a degree of variability, between curve segments for multiple strides within the respective time-dependent signal, in characteristic shapes of the curve segments.” It is unclear from the claim language what in particular the claim is requiring. It appears that the claim requires deriving metric(s) indicating degree of variability in characteristic shapes of the curve segments. However, what in fact the object of the variability analysis is, is not clear. For example, one interpretation would be that the claim is referring to inter-stride variability, in the stride shapes. That is, the shape variability from one curve segment, to another respective curve segment. However, the language, “degree of variability, between curve segments for multiple strides” seems to suggest that the variability in the claims is some variability existing between/in the middle of adjacent curve segments for multiple strides. Claim Rejections - 35 USC § 103 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1 is/are rejected under 35 U.S.C. 103 as being unpatentable over Devanne (“Learning shape variations of motion trajectories for gait analysis”) in view of Rocha (“Parkinson’s Disease Assessment Based on Gait Analysis Using an Innovative RGB-D Camera System”) Regarding claim 1, a method for gait-based testing for a condition in a patient, the method comprising: (Devanne teaches a system for gait analysis by observing a patient’s gait and learning variations in the shape of skeletal motion trajectories during walking. Metrics are computed to evaluate a subject’s gait anomaly, see abstract and Fig. 1.) acquiring gait kinematic data for the patient, the gait kinematic data comprising one or more time-dependent signals each representing a kinematic parameter of a joint or body segment; (Depth video is acquired of a patient walking via a Kinect 2 camera, pg. 898, left column, last paragraph. Skeletal data is extracted and 3D curves are built from the moving joint positions, pg. 869, right column, second paragraph from bottom.) processing the gait kinematic data with one or more computer processors to derive, from the one or more time-dependents signals, one or more respective gait metrics each indicative of a degree of variability, between curve segments for multiple strides within the respective time-dependent signal, in characteristic shapes of the curve segments; and (As above, skeletal data is extracted and 3D curves are built from the moving joint positions, pg. 869, right column, second paragraph from bottom. Also see Figs. 2, and 3 on pg. 897. The curves are segmented by stride, see Fig. 4 on pg. 897. For each stride, 3D shapes are mapped into a shape space as per pg. 897, left column, ¶ 2 and Fig. 5 on pg. 898. Variability in the shapes of the curves, between strides, is analyzed and represented in the shape space. The mean stride shape of a normal step µ is computed from the training data from subjects with a normal gait. Then, each sample shape (each stride step) qi is projected in the shape space tangent to the mean stride shape µ. This sets up each individual stride step to be compared to the mean stride step. Then, using principal component analysis, normal distribution probability density function f(v) is learned. This can characterize the likelihood that any given sample stride step is a “normal” step vs an “abnormal” step. After this, a log-likelihood that each stride step segment corresponds to a normal step is computed as L(s) (see Eq. 7 and pg. 898, left column, ¶ 1-3.) The test sequence, which is a sequence of left or right steps, is represented “as a set of log-likelihoods {L(1), . . . L(s), . . . , L(S)}, being S the number of segments in the test sequence.” Then the test sequence of all the stride step segments S is averaged by similarity measure represented by the D distance which is just a mean of all the log-likelihoods of the sequence (Eq. 8).Kinect depth sensor processors, pg. 1, right column, ¶ 1. Examiner notes that the representation of the stride segments as a set of log-likelihoods {L(1), . . . L(s), . . . , L(S)} is “one or more gait metrics indicative of a degree of variability, between strides, in characteristic shapes of the time-dependent signals.” See further detailed analysis in the response to arguments section.) operating a machine-learning model on input comprising the one or more gait metrics, using the one or more computer processors, to determine at least one predictive score associated with the neurodegenerative condition and the patient. (The machine-learning model is trained at pg. 897, paragraph spanning both columns and pg. 898, paragraph spanning both columns and strides are evaluated using the model. Based on the model, a log-likelihood that a stride is associated with an abnormal gait condition is computed, pg. 898, right column, ¶ 1. A similarity score is then computed as a predictive score of a stride being associated with the gait condition.) In field of gait analysis Rocha teaches predicting that said condition is a neurodegenerative condition. (Rocha is a system for identifying Parkinson’s disease based on gait analysis using an RGB-D sensor capturing gait metrics, see abstract. Additionally, a primary focus of the Rocha paper is feature reduction based upon the set of extracted gait parameters. The discriminative power of a number of features are test and the features which do the best are kept. See pg. 3128, right column, ¶ 1 and 3.) It would have been obvious to one of ordinary skill in the art to have combined Devanne’s machine learning-based gait analysis with Rocha’s machine learning-based gait analysis. Devanne teaches a system for gait analysis using a depth camera to extract a skeletal image and classify a gait as abnormal. Rocha likewise uses a depth camera to extract a skeletal image and classify a gait as abnormal, and further teaches classifying the gait as that of a neurodegenerative condition. The combination simply constitutes the repeatable and predictable result of applying Rocha’s gait analysis technique here. Extending Devanne’s technique to classify the abnormal gait as belonging to a neurodegenerative condition cannot be considered a non-obvious improvement in view of the relevant prior art here. Using known engineering design, no “fundamental” operating principle of the teachings are changed; they continue to perform the same functions as originally taught prior to being combined. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Raphael Schwartz whose telephone number is (571)270-3822. The examiner can normally be reached Monday to Friday 9am-5pm CT. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Vincent Rudolph can be reached at (571) 272-8243. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /RAPHAEL SCHWARTZ/ Examiner, Art Unit 2671
Read full office action

Prosecution Timeline

Apr 10, 2025
Application Filed
Oct 21, 2026
Non-Final Rejection mailed — §103, §112, §DOUBLEPATENT (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12784488
IMAGE PROCESSING-BASED WEIGHT ESTIMATION FOR AQUACULTURE
2y 2m to grant Granted Nov 03, 2026
Patent 12765854
RE-IMAGING DETERMINATION SUPPORT DEVICE, LEARNING DEVICE, RE-IMAGING SUPPORT DEVICE, RECORDING MEDIUM, AND RE-IMAGING DETERMINATION SUPPORT METHOD
3y 8m to grant Granted Oct 20, 2026
Patent 12762708
IMAGE PROCESSING METHOD, IMAGE PROCESSING DEVICE, ELECTRONIC DEVICE, AND STORAGE MEDIUM
2y 10m to grant Granted Oct 13, 2026
Patent 12749218
DISPLAY SYSTEM AND DISPLAY METHOD
2y 0m to grant Granted Sep 29, 2026
Patent 12731273
SYSTEMS AND METHODS FOR IMAGE REGISTRATION OR ALIGNMENT
2y 5m to grant Granted Sep 08, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
67%
Grant Probability
97%
With Interview (+29.7%)
2y 11m (~1y 4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 352 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month